Philip Kaye

8.1k citations
86 papers · 2.6k indexed · 1 hit paper · h-index 26

Impact in

Papers in

Philip Kaye

84 papers receiving 2.5k citations

Hit Papers

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis 2008 · 545 citations
5452008202620142020100200300400500

Peers

Philip Kaye
Comparison fields: 5 of 116
  • Hepatology 414
  • Gastroenterology 207
  • Epidemiology 1.0k
  • Endocrinology, Diabetes and Metabolism 457
  • Surgery 1.1k
Replace Margo Shoup with:
Margo Shoup United States
R. Hultcrantz Sweden
Darius Sorbi United States
Germano Perotti Italy
Ilario de Sio Italy
Kiyoshi Maekawa Japan
Archana Rastogi India
Florencia G. Que United States
Ian D. Norton United States
Fernand Mac–Moune Lai Hong Kong
Philip Kaye relative to Margo Shoup United States Margo Shoup's profile →
Citations per field
00.5×3.7×
Margo Shoup · 1×
Citations per year

Countries citing papers authored by Philip Kaye

Since Specialization
Citations

This map shows the geographic impact of Philip Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kaye more than expected).

Fields of papers citing papers by Philip Kaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kaye. The network helps show where Philip Kaye may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Kaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Kaye Line = papers co-authored together Philip Kaye links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20234
3 20233
4 20217
5 202110
6 202021
7 20185
8 20174
9 20152
10 20151
11 201432
12 201220
13 200933
14
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
Hit paper breakdown →
2008545
15 20071
16 200783
17 20041
18 20032
19 200250
20 200220

About Philip Kaye

Philip Kaye is a scholar working on Gastroenterology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Epidemiology, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (31 papers), Gastric Cancer Management and Outcomes (30 papers), Liver Disease Diagnosis and Treatment (14 papers), Esophageal and GI Pathology (14 papers), Pancreatic and Hepatic Oncology Research (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Liver Disease and Transplantation (6 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Hepatology (414 citations), Gastroenterology (207 citations), Epidemiology (1.0k citations), Endocrinology, Diabetes and Metabolism (457 citations) and Surgery (1.1k citations). Philip Kaye has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Guruprasad P. Aithal, Krish Ragunath, Stephen Ryder, A Austin, Adam Lawson, James A. Thomas, Linda Morgan, Ian Spendlove, George Anagnostopoulos and Irshad Soomro. Their work appears in journals such as Histopathology, Emergency Medicine Journal, Gut, Gastroenterology and Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026